These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7581360)

  • 1. Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy.
    Wells DJ; Wells KE; Asante EA; Turner G; Sunada Y; Campbell KP; Walsh FS; Dickson G
    Hum Mol Genet; 1995 Aug; 4(8):1245-50. PubMed ID: 7581360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice.
    Phelps SF; Hauser MA; Cole NM; Rafael JA; Hinkle RT; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 1995 Aug; 4(8):1251-8. PubMed ID: 7581361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell and gene therapy in Duchenne muscular dystrophy.
    Morgan JE
    Hum Gene Ther; 1994 Feb; 5(2):165-73. PubMed ID: 7514447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A canine minidystrophin is functional and therapeutic in mdx mice.
    Wang B; Li J; Qiao C; Chen C; Hu P; Zhu X; Zhou L; Bogan J; Kornegay J; Xiao X
    Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice.
    Wells DJ; Wells KE; Walsh FS; Davies KE; Goldspink G; Love DR; Chan-Thomas P; Dunckley MG; Piper T; Dickson G
    Hum Mol Genet; 1992 Apr; 1(1):35-40. PubMed ID: 1301134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo.
    Dunckley MG; Wells DJ; Walsh FS; Dickson G
    Hum Mol Genet; 1993 Jun; 2(6):717-23. PubMed ID: 8353491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
    Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
    Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice.
    Ragot T; Vincent N; Chafey P; Vigne E; Gilgenkrantz H; Couton D; Cartaud J; Briand P; Kaplan JC; Perricaudet M
    Nature; 1993 Feb; 361(6413):647-50. PubMed ID: 8437625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
    Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M
    Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
    Koo T; Popplewell L; Athanasopoulos T; Dickson G
    Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA.
    Liu F; Nishikawa M; Clemens PR; Huang L
    Mol Ther; 2001 Jul; 4(1):45-51. PubMed ID: 11472105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dmd(mdx-beta geo): a new allele for the mouse dystrophin gene.
    Wertz K; Füchtbauer EM
    Dev Dyn; 1998 Jun; 212(2):229-41. PubMed ID: 9626497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy in Duchenne muscular dystrophy.
    Inui K; Okada S; Dickson G
    Brain Dev; 1996; 18(5):357-61. PubMed ID: 8891229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.
    Fassati A; Wells DJ; Sgro Serpente PA; Walsh FS; Brown SC; Strong PN; Dickson G
    J Clin Invest; 1997 Aug; 100(3):620-8. PubMed ID: 9239410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm.
    Petrof BJ; Acsadi G; Jani A; Massie B; Bourdon J; Matusiewicz N; Yang L; Lochmüller H; Karpati G
    Am J Respir Cell Mol Biol; 1995 Nov; 13(5):508-17. PubMed ID: 7576685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Codon optimization of the microdystrophin gene for Duchene muscular dystrophy gene therapy.
    Athanasopoulos T; Foster H; Foster K; Dickson G
    Methods Mol Biol; 2011; 709():21-37. PubMed ID: 21194019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy?
    Wilton SD; Dye DE; Blechynden LM; Laing NG
    Neuromuscul Disord; 1997 Jul; 7(5):329-35. PubMed ID: 9267847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides.
    Bertoni C; Rando TA
    Hum Gene Ther; 2002 Apr; 13(6):707-18. PubMed ID: 11936970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.